Skip to main content
Erschienen in: European Journal of Pediatrics 7-8/2003

01.07.2003 | Original Paper

Guidelines for informed consent in biomedical research involving paediatric populations as research participants

verfasst von: Dennis Gill, Ethics Working Group of the Confederation of European Specialists in Paediatrics: Francis P. Crawley (Belgium), Milena LoGiudice (Italy), Stefan Grosek (Slovenia), Ronald Kurz (Austria), Maria de Lourdes-Levy (Portugal), Staffan Mjönes (Sweden), Demetre Nicolopoulos (Greece), Armido Rubino (Italy), Pieter J.J. Sauer (Netherlands), Martti Siimes (Finland), Michael Weinding (UK), Maximilian Zach (Austria), Timothy L. Chambers (UK)

Erschienen in: European Journal of Pediatrics | Ausgabe 7-8/2003

Einloggen, um Zugang zu erhalten

Abstract

To promote and protect the best interests of children involved in biomedical research, paediatricians have to ensure that participating minors and their parents/legal representatives have understood and assented/consented to the research. Therefore guidelines providing child-specific guidance that are compatible with other international guidelines on informed consent are laid down. Special regard is paid to the willingness to participate and the social and cultural background of the patients, the legal conditions of the countries, the capacity of the child to understand and give his/her informed assent, the adequate communication with the child and the parents, the respect of the will of the patient, the understandable written informed consent of legal representatives and to the evaluation of the informed consent/assent process by competent ethics committees.
Literatur
1.
Zurück zum Zitat Committee for Proprietary Medicinal Products /CPMP) (1997) Note for guidance on clinical investigations of medicinal products in children (CPMP/EWP/462/95) London Committee for Proprietary Medicinal Products /CPMP) (1997) Note for guidance on clinical investigations of medicinal products in children (CPMP/EWP/462/95) London
2.
Zurück zum Zitat Council for International Organisations of Medical Sciences (CIOMS) in collaboration with the World Health Organisation (WHO) (1993) International ethical guidelines for biomedical research involving human subjects. Geneva Council for International Organisations of Medical Sciences (CIOMS) in collaboration with the World Health Organisation (WHO) (1993) International ethical guidelines for biomedical research involving human subjects. Geneva
3.
Zurück zum Zitat DeLourdes-Levy M, Larcher V (2003) Informed consent/assent in children. Statement of the Ethics Working Group at the Confederation of European Specialists in Paediatrics (CESP) Eur J Pediatr (in print) DeLourdes-Levy M, Larcher V (2003) Informed consent/assent in children. Statement of the Ethics Working Group at the Confederation of European Specialists in Paediatrics (CESP) Eur J Pediatr (in print)
4.
Zurück zum Zitat Directive 2001/20/EC of the European Parliament and the Council on the approximation of the law, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use (4 April 2001) Luxembourg, http://www.eortc.be/Services/Doc/clinical-EU-directive-04-April-01.pdf Directive 2001/20/EC of the European Parliament and the Council on the approximation of the law, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use (4 April 2001) Luxembourg, http://​www.​eortc.​be/​Services/​Doc/​clinical-EU-directive-04-April-01.​pdf
5.
Zurück zum Zitat Ethics Working Group of the Confederation of European Specialists in Paediatrics (CESP) (2002) Ethical principles and operational guidelines for good clinical practice in paediatric research. Recommendations of the Ethics Working Group of CESP. The EFGCP Annual Conference 24–25 January 2002, Conference Documents, Brüssels, http://www.efgcp.org Ethics Working Group of the Confederation of European Specialists in Paediatrics (CESP) (2002) Ethical principles and operational guidelines for good clinical practice in paediatric research. Recommendations of the Ethics Working Group of CESP. The EFGCP Annual Conference 24–25 January 2002, Conference Documents, Brüssels, http://​www.​efgcp.​org
6.
Zurück zum Zitat International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) (2000) ICH Topic E11: Note for guidance on clinical investigations of medicinal products in the paediatric population (CPMP/ICH 135/95). London, hppt://www.ich.org International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) (2000) ICH Topic E11: Note for guidance on clinical investigations of medicinal products in the paediatric population (CPMP/ICH 135/95). London, hppt://www.ich.org
7.
Zurück zum Zitat Ondrusek N, Abramoovitch R, Pencharz P, Koren G (1998) Empirical examination of the ability of children to consent to clinical research. J Med Ethics 24: 158–165CrossRefPubMedPubMedCentral Ondrusek N, Abramoovitch R, Pencharz P, Koren G (1998) Empirical examination of the ability of children to consent to clinical research. J Med Ethics 24: 158–165CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Sauer PJJ (2002) Research in children: report on behalf of the Ethics Working Group of CESP. Eur J Pediatr 161: 1–5CrossRefPubMed Sauer PJJ (2002) Research in children: report on behalf of the Ethics Working Group of CESP. Eur J Pediatr 161: 1–5CrossRefPubMed
9.
Zurück zum Zitat United Nations Children's Fund (1995) The Convention on the Rights of the Child. UK Committee for UNICEF. London, http://www.unicef.org/crc/crc.htm United Nations Children's Fund (1995) The Convention on the Rights of the Child. UK Committee for UNICEF. London, http://​www.​unicef.​org/​crc/​crc.​htm
10.
Zurück zum Zitat World Medical Association (2000) Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. 52nd General Assembly, Edinburgh, Scotland, October 2000, http://www.wma.net/e/policy/17-c e.html World Medical Association (2000) Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. 52nd General Assembly, Edinburgh, Scotland, October 2000, http://​www.​wma.​net/​e/​policy/​17-c e.html
Metadaten
Titel
Guidelines for informed consent in biomedical research involving paediatric populations as research participants
verfasst von
Dennis Gill
Ethics Working Group of the Confederation of European Specialists in Paediatrics: Francis P. Crawley (Belgium), Milena LoGiudice (Italy), Stefan Grosek (Slovenia), Ronald Kurz (Austria), Maria de Lourdes-Levy (Portugal), Staffan Mjönes (Sweden), Demetre Nicolopoulos (Greece), Armido Rubino (Italy), Pieter J.J. Sauer (Netherlands), Martti Siimes (Finland), Michael Weinding (UK), Maximilian Zach (Austria), Timothy L. Chambers (UK)
Publikationsdatum
01.07.2003
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 7-8/2003
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-003-1192-0

Weitere Artikel der Ausgabe 7-8/2003

European Journal of Pediatrics 7-8/2003 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.